Frekhtman & Associates

Facebook

Twitter

Copyright 2003 by Frekhtman & Associates.
All Rights Reserved.
COVID-19 NOTICE: We are open and fully operational.
Our law firm is following CDC safety regulations, We are available by phone, email, text/chat, or video.

NO FEE
PROMISE

(866) 288-9529

24/7 Free & Confidential Consultations

Search
Menu
 

Actos Bladder Cancer Lawyers | Actos Injury Attorney

Actos Bladder Cancer Lawyers | Actos Injury Attorney

Actos Lawyers, F&A represents patients who have been diagnosed with bladder cancer after having taken prescription drug Actos (pioglitazone). This medication is usually prescribed for individuals with Type 2 diabetes and is manufactured by Takeda Pharmaceutical Company, Ltd., a Japanese company.

The US Food & Drug Administration issued a safety alert in June 2011 informing the public that use of Actos for more than one year may be linked to an increased risk of bladder cancer. Several european countries including France have banned Actos. While Takeda changed the label on the drug to warn patients of this increased bladder cancer risk, such a warning may not be enough.

Canada similarly issued a safety warning in April of 2012.

Several patients who took Actos to manage their diabetes and were diagnosed with bladder cancer afterwards have already filed lawsuits against Takeda. The suits allege that the pharmaceutical manufacturer should have known using reasonable care that Actos causes bladder cancer. Some of the suits claim that Takeda had studies on laboratory animals which also confirmed an increased risk of bladder cancer. Those studies were in Takeda’s possession before they introduced the drug to the public market in 1999 but the company failed to inform health regulators, any governmental agency, or the public about these studies or their results.

Actos lawsuit summons and complaints also allege that Takeda did not investigate or examine the link between Actos and bladder cancer. No clinical studies on humans were conducted. The manufacturer marketed and sold Actos with no warnings to doctors or their patients that taking this drug may cause cancer of the bladder.

In 2003, a group of doctors, presented a study at the American Academy of Opthalmology which found a relationship between use of Actos and macular edema. The study actually found that Actos “appears to be a cause of macular edema” which is bulging or swelling of the macula, the part of the eye who regulates detailed vision. Macular edema leads to loss of vision which may be small or extremely severe.

In 2009, another study by physicians found that diabetes patients who took Actos were more likely to develop macular edema than diabetes patients who did not take this drug. The study examined nearly 200,000 diabetes patients.

If you or a loved one is taking Actos and suffered vision loss due to macular edema or has been diagnosed with bladder cancer, contact Frekhtman & Associates for a free consultation. We will investigate your claim and recover compensation if we accept your case. There is never any fee due from our clients. Our recovery is a percentage of the money we win for you.

Email us or call (855) DRUG HURT. (855) 378-4487.

No Comments

Sorry, the comment form is closed at this time.